{"commentary":{"count":127,"free_build_floor":8,"listing_floor":3,"by_channel":{"x_thread":78,"youtube":25,"podcast":22,"x_video":2},"note":"Indexed podcasts, YouTube videos and X posts that name this trial. A report screens them, searches for more and cites what clinicians said when it is built."},"free_build":{"available":true,"how":"POST https://www.erudio.com/api/trial-requests with {\"nct_id\": \"NCT02597348\", \"email\": \"<work email>\"}. The person who owns that inbox must confirm by the emailed link; agents cannot confirm. The result is the report's public preview; the full report is still bought."},"name":"TRANSMET","nct_id":"NCT02597348","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=transmet-nct02597348. The price is fixed at order. We build the report after the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":1950,"size":"deep","size_rule":"Deep: 41+ commentary sources"},"registry":{"acronym":"TRANSMET","arms":[{"description":"Arm LT+C: patients will be treated by experimental liver transplantation preceding the non experimental standard chemotherapy (according to usual practices).","label":"Liver Transplantation","type":"EXPERIMENTAL"},{"description":"Arm C: patients will receive non experimental standard chemotherapy according to usual practices in the context of definitively unresectable CLM.","label":"No intervention","type":"NO_INTERVENTION"}],"collaborators":[],"completion_date":{"date":"2026-07","type":"ESTIMATED"},"conditions":["Liver Metastasis","Colorectal Cancer","Metastasis"],"enrollment":{"count":94,"type":"ACTUAL"},"has_results":false,"interventions":[{"name":"Liver Transplantation","type":"PROCEDURE"}],"last_update":"2024-02-14","lead_sponsor":"Assistance Publique - Hôpitaux de Paris","official_title":"Curative Potential of Liver Transplantation in Patients With Definitively Unresectable Colorectal Liver Metastases (CLM) Treated by Chemotherapy: a Prospective Multicentric Randomized Trial","overall_status":"UNKNOWN","phases":["NA"],"primary_completion_date":{"date":"2026-07","type":"ESTIMATED"},"primary_outcomes":[{"measure":"5 years overall survival (OS)","timeFrame":"5 years"}],"references":[{"citation":"Adam R, Piedvache C, Chiche L, Adam JP, Salame E, Bucur P, Cherqui D, Scatton O, Granger V, Ducreux M, Cillo U, Cauchy F, Mabrut JY, Verslype C, Coubeau L, Hardwigsen J, Boleslawski E, Muscari F, Jeddou H, Pezet D, Heyd B, Lucidi V, Geboes K, Lerut J, Majno P, Grimaldi L, Levi F, Lewin M, Gelli M; Collaborative TransMet group. Liver transplantation plus chemotherapy versus chemotherapy alone in patients with permanently unresectable colorectal liver metastases (TransMet): results from a multicentre, open-label, prospective, randomised controlled trial. Lancet. 2024 Sep 21;404(10458):1107-1118. doi: 10.1016/S0140-6736(24)01595-2.","pmid":"39306468","type":"DERIVED"}],"start_date":{"date":"2016-02","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"Liver Transplantation in Patients With Unresectable Colorectal Liver Metastases Treated by Chemotherapy","url":"https://clinicaltrials.gov/study/NCT02597348"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"2.0","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/transmet-nct02597348"}